TRUE3D
Live / Applied — Non-final action mailed (as of 30 Oct 2026)
Now
Refused for now — an office action was mailed 30 Oct 2026.
A response is due by 30 Jan 2027; with no response the application is abandoned.
What this means for you
Not registered yet, but its 17 Jun 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99890985
- Mark type
- Word mark
- Filed
- 17 Jun 2026
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 001 — Chemicals: Chemical reagents for scientific and research use, namely, multi-omic reagents for research, scientific, and clinical laboratory use; Biomarker reagents for research, scientific, and clinical laboratory use
- Class 005 — Pharmaceuticals: Clinical medical reagents, namely, multi-omic reagents for medical use; Diagnostic biomarker reagents for clinical medical purposes
- Class 009 — Scientific and electric apparatus: Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of biomolecules and spatial interactions between biomolecules and cells in situ; Medical laboratory research instruments for in situ multi-omic analysis, spatial transcriptomics, and protein analysis
- Class 010 — Medical apparatus: Medical instruments, namely, instruments for in situ multi-omic analysis, for diagnostic purposes
- Class 042 — Scientific and technological services: Scientific research and analysis, namely, in situ multi-omic research and analysis, spatial transcriptomics research and analysis, and protein research and analysis; Clinical research in the fields of in situ multi-omic analysis, spatial transcriptomics, and protein analysis; Analysis, evaluation, and development of therapeutics medicines for research, scientific, and clinical use
- Class 044 — Medical, beauty and agricultural services: Medical diagnostic testing and reporting services in the fields of in situ multi-omic analysis, spatial transcriptomics, and protein analysis
Owner
- Stellaromics, Inc., Boston, MA, US
Prosecution history
- 30 Oct 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Oct 2026 — NON-FINAL ACTION E-MAILED
- 30 Oct 2026 — NON-FINAL ACTION WRITTEN
- 27 Oct 2026 — ASSIGNED TO EXAMINER
- 26 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Jun 2026 — APPLICATION FILING RECEIPT MAILED
- 17 Jun 2026 — NEW APPLICATION ENTERED